MoneyWorks4Me

Genpharmasec - Quaterly Results

22 May 2026 Evaluate
The total revenue hovered 281.12% to Rs. 516.64 millions for the March 2026 quarter as against Rs. 135.56 millions during the corresponding quarter last year.The Total Profit for the quarter ended March 2026 of Rs. 23.17 millions grew from Rs.-2.40 millionsOperating profit surged to 32.04 millions from the corresponding previous quarter of 0.51 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 516.64 135.56 281.12 1313.49 329.61 298.50 1313.49 329.61 298.50
Other Income 16.18 10.60 52.64 48.69 34.31 41.91 48.69 34.31 41.91
PBIDT 32.04 0.51 6182.35 72.87 41.89 73.96 72.87 41.89 73.96
Interest 2.48 0.60 313.33 5.94 2.78 113.67 5.94 2.78 113.67
PBDT 29.56 -0.09 -32944.44 66.93 39.11 71.13 66.93 39.11 71.13
Depreciation 0.94 0.40 135.00 2.56 1.33 92.48 2.56 1.33 92.48
PBT 28.62 -0.49 -5940.82 64.37 37.78 70.38 64.37 37.78 70.38
TAX 5.45 1.91 185.34 9.87 9.78 0.92 9.87 9.78 0.92
Deferred Tax -0.83 -0.64 29.69 -1.77 2.90 -161.03 -1.77 2.90 -161.03
PAT 23.17 -2.40 -1065.42 54.50 28.00 94.64 54.50 28.00 94.64
Equity 553.72 553.72 0.00 553.72 553.72 0.00 553.72 553.72 0.00
PBIDTM(%) 6.20 0.38 1548.48 5.55 12.71 -56.35 5.55 12.71 -56.35
Peers